Alexander T Sandhu1, Shun Kohsaka1,2, Jay Bhattacharya3,4, William F Fearon1, Robert A Harrington1, Paul A Heidenreich1,5. 1. Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California. 2. Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. 3. Center for Health Policy, Department of Medicine, Stanford University, Stanford, California. 4. Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University, Stanford, California. 5. Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Abstract
Importance: Multiple states publicly report a hospital's risk-adjusted mortality rate for percutaneous coronary intervention (PCI) as a quality measure. However, whether reported annual PCI mortality is associated with a hospital's future performance is unclear. Objective: To evaluate the association between reported risk-adjusted hospital PCI-related mortality and a hospital's future PCI-related mortality. Design, Setting, and Participants: This study used data from the New York Percutaneous Intervention Reporting System from January 1, 1998, to December 31, 2016, to assess hospitals that perform PCI. Exposures: Public-reported, risk-adjusted, 30-day mortality after PCI. Main Outcomes and Measures: The primary analysis evaluated the association between a hospital's reported risk-adjusted PCI-related mortality and future PCI-related mortality. The correlation between a hospital's observed to expected (O/E) PCI-related mortality rates each year and future O/E mortality ratios was assessed. Multivariable linear regression was used to examine the association between index year O/E mortality and O/E mortality in subsequent years while adjusting for PCI volume and patient severity. Results: This study included 67 New York hospitals and 960 hospital-years. Hospitals with low PCI-related mortality (O/E mortality ratio, ≤1) and high mortality (O/E mortality ratio, >1) had inverse associations between their O/E mortality ratio in the index year and the subsequent change in the ratio (hospitals with low mortality, r = -0.45; hospitals with high mortality, r = -0.60). Little of the variation in risk-adjusted mortality was explained by prior performance. An increase in the O/E mortality ratio from 1.0 to 2.0 in the index year was associated with a higher O/E mortality ratio of only 0.15 (95% CI, 0.02-0.27) in the following year. Conclusions and Relevance: At hospitals with high or low PCI-related mortality rates, the rates largely regressed to the mean the following year. A hospital's risk-adjusted mortality rate was poorly associated with its future mortality. The annual hospital PCI-related mortality may not be a reliable factor associated with hospital quality to consider in a practice change or when helping patients select high-quality hospitals.
Importance: Multiple states publicly report a hospital's risk-adjusted mortality rate for percutaneous coronary intervention (PCI) as a quality measure. However, whether reported annual PCI mortality is associated with a hospital's future performance is unclear. Objective: To evaluate the association between reported risk-adjusted hospital PCI-related mortality and a hospital's future PCI-related mortality. Design, Setting, and Participants: This study used data from the New York Percutaneous Intervention Reporting System from January 1, 1998, to December 31, 2016, to assess hospitals that perform PCI. Exposures: Public-reported, risk-adjusted, 30-day mortality after PCI. Main Outcomes and Measures: The primary analysis evaluated the association between a hospital's reported risk-adjusted PCI-related mortality and future PCI-related mortality. The correlation between a hospital's observed to expected (O/E) PCI-related mortality rates each year and future O/E mortality ratios was assessed. Multivariable linear regression was used to examine the association between index year O/E mortality and O/E mortality in subsequent years while adjusting for PCI volume and patient severity. Results: This study included 67 New York hospitals and 960 hospital-years. Hospitals with low PCI-related mortality (O/E mortality ratio, ≤1) and high mortality (O/E mortality ratio, >1) had inverse associations between their O/E mortality ratio in the index year and the subsequent change in the ratio (hospitals with low mortality, r = -0.45; hospitals with high mortality, r = -0.60). Little of the variation in risk-adjusted mortality was explained by prior performance. An increase in the O/E mortality ratio from 1.0 to 2.0 in the index year was associated with a higher O/E mortality ratio of only 0.15 (95% CI, 0.02-0.27) in the following year. Conclusions and Relevance: At hospitals with high or low PCI-related mortality rates, the rates largely regressed to the mean the following year. A hospital's risk-adjusted mortality rate was poorly associated with its future mortality. The annual hospital PCI-related mortality may not be a reliable factor associated with hospital quality to consider in a practice change or when helping patients select high-quality hospitals.
Authors: Edward L Hannan; Kimberly Cozzens; Spencer B King; Gary Walford; Nirav R Shah Journal: J Am Coll Cardiol Date: 2012-06-19 Impact factor: 24.094
Authors: Jacob A Doll; Dadi Dai; Matthew T Roe; John C Messenger; Matthew W Sherwood; Abhiram Prasad; Ehtisham Mahmud; John S Rumsfeld; Tracy Y Wang; Eric D Peterson; Sunil V Rao Journal: JACC Cardiovasc Interv Date: 2017-04-10 Impact factor: 11.195
Authors: Rishi K Wadhera; Colin W O'Brien; Karen E Joynt Maddox; Kalon K L Ho; Duane S Pinto; Frederic S Resnic; Pinak B Shah; Robert W Yeh Journal: J Am Coll Cardiol Date: 2019-03-15 Impact factor: 24.094
Authors: Daniel M Blumenthal; Linda R Valsdottir; Yuansong Zhao; Changyu Shen; Ajay J Kirtane; Duane S Pinto; Fred S Resnic; Karen E Joynt Maddox; Jason H Wasfy; Roxana Mehran; Ken Rosenfield; Robert W Yeh Journal: JAMA Cardiol Date: 2018-07-01 Impact factor: 14.676
Authors: Stephen W Waldo; James M McCabe; Cashel O'Brien; Kevin F Kennedy; Karen E Joynt; Robert W Yeh Journal: J Am Coll Cardiol Date: 2015-03-24 Impact factor: 24.094